The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

被引:160
|
作者
Zhai, Bing [1 ]
Wu, Cheng [1 ]
Wang, Linqi [1 ]
Sachs, Matthew S. [1 ]
Lin, Xiaorong [1 ]
机构
[1] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA
基金
美国国家卫生研究院;
关键词
SEROTONIN REUPTAKE INHIBITORS; OBSESSIVE-COMPULSIVE DISORDER; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; ANTIFUNGAL ACTIVITY; DRUG DEVELOPMENT; AMPHOTERICIN-B; FLUCONAZOLE; NEOFORMANS; TARGET;
D O I
10.1128/AAC.00212-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Therapeutic treatment for systemic mycoses is severely hampered by the extremely limited number of antifungals. The difficulty of treatment of fungal infections in the central nervous system is further compounded by the poor central nervous system (CNS) penetration of most antifungals due to the blood-brain barrier. Only a few fungistatic azole drugs, such as fluconazole, show reasonable CNS penetration. Here we demonstrate that sertraline (Zoloft), the most frequently prescribed antidepressant, displays potent antifungal activity against Cryptococcus neoformans, the major causative agent of fungal meningitis. In in vitro assays, this neurotropic drug is fungicidal to all natural Cryptococcus isolates tested at clinically relevant concentrations. Furthermore, sertraline interacts synergistically or additively with fluconazole against Cryptococcus. Importantly, consistent with our in vitro observations, sertraline used alone reduces the brain fungal burden at an efficacy comparable to that of fluconazole in a murine model of systemic cryptococcosis. It works synergistically with fluconazole in reducing the fungal burden in brain, kidney, and spleen. In contrast to its potency against Cryptococcus, sertraline is less effective against strains of Candida species and its interactions with fluconazole against Candida strains are often antagonistic. Therefore, our data suggest the unique application of sertraline against cryptococcosis. To understand the antifungal mechanisms of sertraline, we screened a whole-genome deletion collection of Saccharomyces cerevisiae for altered sertraline susceptibility. Gene ontology analyses of selected mutations suggest that sertraline perturbs translation. In vitro translation assays using fungal cell extracts show that sertraline inhibits protein synthesis. Taken together, our findings indicate the potential of adopting this antidepressant in treating cryptococcal meningitis.
引用
收藏
页码:3758 / 3766
页数:9
相关论文
共 50 条
  • [1] Secukinumab: a promising therapeutic option in spondyloarthritis
    Hernan Maldonado-Ficco
    Rodolfo Perez-Alamino
    José A. Maldonado-Cocco
    Clinical Rheumatology, 2016, 35 : 2151 - 2161
  • [2] Secukinumab: a promising therapeutic option in spondyloarthritis
    Maldonado-Ficco, Hernan
    Perez-Alamino, Rodolfo
    Maldonado-Cocco, Jose A.
    CLINICAL RHEUMATOLOGY, 2016, 35 (09) : 2151 - 2161
  • [3] DMF: a promising therapeutic option in CTCL
    Vancurova, Ivana
    BLOOD, 2016, 128 (06) : 745 - 746
  • [5] Ghrelin as a Promising Therapeutic Option for Cancer Cachexia
    Khatib, Mahalaqua Nazli
    Gaidhane, Abhay
    Gaidhane, Shilpa
    Quazi Syed, Zahiruddin
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (05) : 2172 - 2188
  • [6] Cefepime-tazobactam: A promising therapeutic option
    Panchatcharam, S. N.
    Ramasubramanian, V.
    Gopalakrishnan, R.
    Ghafur, A.
    Thirunarayan, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E470 - E471
  • [7] Cytokine blockade - a promising therapeutic option in SLE
    Aringer, M.
    Feierl, E.
    Smolen, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2008, 67 (04): : 315 - 317
  • [8] The antidepressant sertraline provides a novel host directed therapy module for augmenting TB therapy
    Shankaran, Deepthi
    Singh, Anjali
    Dawa, Stanzin
    Arumugam, Prabhakar
    Gandotra, Sheetal
    Rao, Vivek
    Kana, Bavesh D.
    ELIFE, 2023, 12
  • [9] Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis
    Meissner, M.
    Bauer, R.
    Beier, C.
    Betz, C.
    Wolter, M.
    Kaufmann, R.
    Gille, J.
    DERMATOLOGY, 2006, 212 (04) : 373 - 376
  • [10] Neurostimulation A promising therapeutic option for medically refractory epilepsy
    Hassan, Ali
    Al-Quliti, Khalid W.
    NEUROSCIENCES, 2014, 19 (01) : 4 - 10